Health and Fitness Health and Fitness
Thu, November 8, 2012
[ Thu, Nov 08th 2012 ] - Market Wire
Discovery Labs Reports Third Quarter 2012 Financial Results
[ Thu, Nov 08th 2012 ] - Market Wire
Boston Scientific to Acquire Vessix Vascular, Inc.
[ Thu, Nov 08th 2012 ] - Market Wire
Cornerstone Therapeutics Acquires Exclusive U.S. .. S.p.A.'s BETHKIS(R) (Tobramycin Inhalation Solut
[ Thu, Nov 08th 2012 ] - Market Wire
Milestone Scientific and Aseptico Form Strategic Alliance
[ Thu, Nov 08th 2012 ] - Market Wire
JAMA Study Demonstrates Efficacy of Life Technolo .. ecting Early Metastases, Supports Screening for L
[ Thu, Nov 08th 2012 ] - Market Wire
Aeterna Zentaris Presents Proof-of-Concept for Di .. s, such as AEZS-125, in Ovarian Cancer Mouse Mode
[ Thu, Nov 08th 2012 ] - Market Wire
Rigel to Present at Jefferies 2012 Global Healthcare Conference in London
[ Thu, Nov 08th 2012 ] - Market Wire
MethylGene Presents MGCD265 Data at the 24th EORT .. sium on Molecular Targets and Cancer Therapeutics
[ Thu, Nov 08th 2012 ] - Market Wire
Omeros to Present Data from Successful OMS302 Pha .. American Academy of Ophthalmology Annual Meeting
Wed, November 7, 2012
[ Wed, Nov 07th 2012 ] - Market Wire
GLPG0634 Phase 2A multicenter trial shows dose-re .. fety and significant clinical benefit in rheumato
[ Wed, Nov 07th 2012 ] - Market Wire
Quidel Receives CE Mark for Its Sofia(R) Legionella Fluorescent Immunoassay (FIA)
[ Wed, Nov 07th 2012 ] - Market Wire
Leisureworld Senior Care Corporation Reports Strong 2012 Third Quarter Results, Increases Dividend
[ Wed, Nov 07th 2012 ] - Market Wire
Stem Cell Therapeutics Announces Agreement With U .. MaRS Innovation for Novel, Clinical-Stage, Cancer
[ Wed, Nov 07th 2012 ] - Market Wire
Milestone Scientific Schedules Third Quarter 2012 Earnings Conference Call
[ Wed, Nov 07th 2012 ] - Market Wire
Sarepta Therapeutics Announces Third Quarter 2012 .. nancial Results and Recent Corporate Developments
[ Wed, Nov 07th 2012 ] - Market Wire
NuPathe to Present at the 9th Annual Lazard Healthcare Conference
[ Wed, Nov 07th 2012 ] - Market Wire
Depomed Reports Top Line Data for Phase 2 Study in Parkinson's Disease
[ Wed, Nov 07th 2012 ] - Market Wire
Array BioPharma to Present at the Lazard Annual H .. and Jefferies 2012 Global Healthcare Conferences
[ Wed, Nov 07th 2012 ] - Market Wire
Allied Healthcare Reports First Quarter Loss
[ Wed, Nov 07th 2012 ] - Market Wire
Edwards Lifesciences to Present at the Credit Suisse 2012 Healthcare Conference
[ Wed, Nov 07th 2012 ] - Market Wire
RepliCel Completes First Pre-Filing Review with G .. its RCH-01 Autologous Hair Cell Manufacturing Pro
[ Wed, Nov 07th 2012 ] - Market Wire
Quidel to Present at Credit Suisse 2012 Healthcare Conference
[ Wed, Nov 07th 2012 ] - Market Wire
EnteroMedics Announces EMPOWER Trial Hypertension .. ican Heart Association's 2012 Scientific Sessions
[ Wed, Nov 07th 2012 ] - Market Wire
Express Scripts to Present at Investor Conferences in November
[ Wed, Nov 07th 2012 ] - Market Wire
Cantel Medical Appoints Jorgen B. Hansen As Executive Vice President And Chief Operating Officer
[ Wed, Nov 07th 2012 ] - Market Wire
BIOLASE to Present at Lazard Capital Markets 9th Annual Healthcare Conference
[ Wed, Nov 07th 2012 ] - Market Wire
VELscope Reaches 25 Million Oral Cancer Exams Milestone
[ Wed, Nov 07th 2012 ] - Market Wire
John A. Orwin Joins Array BioPharma Board Of Directors
[ Wed, Nov 07th 2012 ] - Market Wire
Cornerstone Therapeutics Announces Alastair McEwan as Chief Financial Officer
[ Wed, Nov 07th 2012 ] - Market Wire
Johnson amp;; Johnson to Participate in Credit Suisse 2012 Healthcare Conference

Johnson amp;; Johnson to Participate in Credit Suisse 2012 Healthcare Conference


Published on 2012-11-07 06:01:09 - Market Wire
  Print publication without navigation


Johnson & Johnson to Participate in Credit Suisse 2012 Healthcare Conference -- NEW BRUNSWICK, N.J., Nov. 7, 2012 /PRNewswire/ --

NEW BRUNSWICK, N.J., Nov. 7, 2012 /PRNewswire/ -- Johnson & Johnson (NYSE: [ JNJ ]) will participate in the Credit Suisse 2012 Healthcare Conference Wednesday, Nov. 14th, at the Arizona Biltmore Hotel, 2400 E. Missouri Avenue, Phoenix, AZ.   Dominic Caruso, Vice President, Finance & Chief Financial Officer, will represent the company in a session scheduled at 11:00 a.m. (Mountain Standard Time).

This broadcast will be available to interested investors and parties by accessing the Johnson & Johnson website at [ www.investor.jnj.com ].

A webcast and podcast replay will be available shortly after the live webcast.

SOURCE Johnson & Johnson



RELATED LINKS
[ http://www.investor.jnj.com ]
Contributing Sources